Blackstone Secures $12.6M in Financing, Plans to Sharpen Life Science Focus | GenomeWeb

NEW YORK, June 4 – Blackstone Technology Group, a provider of high-throughput computing software and services based in Worcester, Mass., said Monday it has closed a $12.6 million Series B round of venture financing led by Ampersand Ventures. 

Co-investors in the funding included Softbank Investment Corp., Garfly Invest AG, Itochu International, and Synopsys. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.